These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31004029)

  • 1. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.
    Goyal G; Ravindran A; Young JR; Shah MV; Bennani NN; Patnaik MM; Nowakowski GS; Thanarajasingam G; Habermann TM; Vassallo R; Sher T; Parikh SA; Rech KL; Go RS;
    Haematologica; 2020; 105(2):348-357. PubMed ID: 31004029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
    Haroche J; Abla O
    Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
    Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
    Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
    Salama HA; Jazieh AR; Alhejazi AY; Absi A; Alshieban S; Alzahrani M; Alaskar A; Gmati G; Damlaj M; Abuelgasim KA; Alghamdi A; Alahmari B; Almugairi A; Alzahrani H; Bazarbachi A; Musa MOH; Goyal G
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e66-e75. PubMed ID: 32943371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological Manifestations of Histiocytic Disorders.
    Banks SA; Sartori Valinotti JC; Go RS; Abeykoon JP; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Bennani NN; Shah MV; Rech KL; Tobin WO;
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):277-286. PubMed ID: 37209319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rosai-Dorfman disease: Diagnosis and therapeutic challenges].
    Cohen Aubart F; Haroche J; Emile JF; Charlotte F; Barete S; Schleinitz N; Donadieu J; Amoura Z
    Rev Med Interne; 2018 Aug; 39(8):635-640. PubMed ID: 29501513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking.
    Gallego CT; Bueno J; Cruces E; Stelow EB; Mancheño N; Flors L
    Radiologia (Engl Ed); 2019; 61(3):215-224. PubMed ID: 30686482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.
    Goyal G; Young JR; Koster MJ; Tobin WO; Vassallo R; Ryu JH; Davidge-Pitts CJ; Hurtado MD; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Go RS;
    Mayo Clin Proc; 2019 Oct; 94(10):2054-2071. PubMed ID: 31472931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].
    Bösmüller H; Nann D; Horger M; Fend F
    Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraosseous Rosai-Dorfman disease diagnosed by touch imprint cytology evaluation: A case series.
    Pendse AA; Wobker SE; Greene KG; Smith SV; Esther RJ; Dodd LG
    Diagn Cytopathol; 2018 Jan; 46(1):83-87. PubMed ID: 28834636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
    Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
    Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histiocytosis.
    Rocamora-Blanch G; Climent F; Solanich X
    Med Clin (Barc); 2023 Aug; 161(4):166-175. PubMed ID: 37263840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib.
    Portegys J; Heidemeier A; Rosenwald A; Gernert M; Fröhlich M; Hueper S; Strunz PP; Rasche L; Schmalzing M
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36693681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of Rosai-Dorfman disease involving the central nervous system.
    Adeleye AO; Amir G; Fraifeld S; Shoshan Y; Umansky F; Spektor S
    Neurol Res; 2010 Jul; 32(6):572-8. PubMed ID: 20350368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Musculoskeletal imaging features of non-Langerhans cell histiocytoses.
    Choraria A; Andrei V; Rajakulasingam R; Saifuddin A
    Skeletal Radiol; 2021 Oct; 50(10):1921-1940. PubMed ID: 33787962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosai Dorfman disease.
    Khan MK; Khan MK; Sultana SZ
    Mymensingh Med J; 2008 Jul; 17(2 Suppl):S97-9. PubMed ID: 18946460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic Rosai-Dorfman-Destombes disease associated with a myelodysplastic syndrome. Efficacy of hematologic treatment].
    Deshayes R; Eustache M; Moreau A; Péterlin P; Néel A; Masseau A; Bodet-Milin C; Hamidou M
    Rev Med Interne; 2021 Apr; 42(4):281-284. PubMed ID: 33485702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAF
    Pieri V; Berzero G; Paterra R; Ferré L; Tomelleri A; Campochiaro C; Esposito F; Calimeri T; Cangi MG; Tenace NP; Ferreri AJM; Castellano A; Barbera M; Anzalone N; Gay LG; Bello L; Colecchia M; Ponzoni M; Finocchiaro G; Filippi M
    J Neurol; 2024 Jan; 271(1):575-579. PubMed ID: 37725109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.